Clinical trial
Investigator-initiated, Placebo-controlled, Randomized Trial to Assess the Efficacy and Safety of Platelet Inhibition and/ or Lipid Lowering in Non-ACS-patients With Elevated High-sensitivity Troponin Values
NCT03820466 is registered in ClinicalTrials.gov with Dr. med. Mahir Karakas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigator-initiated, Placebo-controlled, Randomized Trial to Assess the Efficacy and Safety of Platelet Inhibition and/ or Lipid Lowering in Non-ACS-patients With Elevated High-sensitivity Troponin Values
- Lead sponsor
- Dr. med. Mahir Karakas
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- February 21, 2020
- Completion date
- April 7, 2022
- Enrollment
- 68 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.